HCV therapy in HIV-infected patients

被引：26

作者：

Sulkowski, Mark S. ^{[1
]}

机构：

[1] Johns Hopkins Univ, Sch Med, Baltimore, MD 21287 USA

来源：

LIVER INTERNATIONAL | 2013年 / 33卷

基金：

美国国家卫生研究院;

关键词：

boceprevir; co-infection; hepatitis C virus; HIV; telaprevir; GENOTYPE; 1; INFECTION; HEPATITIS-C; ACTING ANTIVIRALS; BOCEPREVIR; TELAPREVIR; MANAGEMENT; VIRUS;

D O I：

10.1111/liv.12082

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Hepatitis C virus (HCV) co-infection is common among HIV-infected patients. Over the past 15years, effective HIV treatment has led to dramatic reductions in the incidence of AIDS-related death; over the same time period, HCV-related liver disease has emerged as a major cause of morbidity and mortality. Treatment with peginterferon (PEG-IFN) and ribavirin (RBV) has been recommended for the treatment of HCV infection in HIV-infected patients at the greatest risk of developing liver disease. However, the effectiveness of this HCV treatment has been low because of limited efficacy in patients infected with HCV genotype 1. More recently, HCV NS3/4A protease inhibitors, telaprevir and boceprevir, in combination with PEG-IFN/RBV have led to significantly higher sustained viral response rates in HIV-uninfected patients with HCV genotype 1 infection. The potential use of these agents in patients with HIV/HCV co-infection is complicated by the potential for drug interactions between antiretroviral drugs and the HCV protease inhibitors and uncertainty regarding the safety and effectiveness of the combination therapy in this population.

引用

页码：63 / 67

页数：5

共 12 条

[1] Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].

Bacon, Bruce R. ;

Gordon, Stuart C. ;

Lawitz, Eric ;

Marcellin, Patrick ;

Vierling, John M. ;

Zeuzem, Stefan ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Poordad, Fred ;

Goodman, Zachary D. ;

Sings, Heather L. ;

Boparai, Navdeep ;

Burroughs, Margaret ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Esteban, Rafael .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217

[2]

Dieterich DT, 2012, TELAPREVIR COMBINATI

[3] Diagnosis, Management, and Treatment of Hepatitis C: An Update [J].

Ghany, Marc G. ;

Strader, Doris B. ;

Thomas, David L. ;

Seeff, Leonard B. .

HEPATOLOGY, 2009, 49 (04) :1335-1374

[4] Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection [J].

Jacobson, Ira M. ;

McHutchison, John G. ;

Dusheiko, Geoffrey ;

Di Bisceglie, Adrian M. ;

Reddy, K. Rajender ;

Bzowej, Natalie H. ;

Marcellin, Patrick ;

Muir, Andrew J. ;

Ferenci, Peter ;

Flisiak, Robert ;

George, Jacob ;

Rizzetto, Mario ;

Shouval, Daniel ;

Sola, Ricard ;

Terg, Ruben A. ;

Yoshida, Eric M. ;

Adda, Nathalie ;

Bengtsson, Leif ;

Sankoh, Abdul J. ;

Kieffer, Tara L. ;

George, Shelley ;

Kauffman, Robert S. ;

Zeuzem, Stefan .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25) :2405-2416

[5] Effect of Early versus Deferred Antiretroviral Therapy for HIV on Survival [J].

Kitahata, Mari M. ;

Gange, Stephen J. ;

Abraham, Alison G. ;

Merriman, Barry ;

Saag, Michael S. ;

Justice, Amy C. ;

Hogg, Robert S. ;

Deeks, Steven G. ;

Eron, Joseph J. ;

Brooks, John T. ;

Rourke, Sean B. ;

Gill, M. John ;

Bosch, Ronald J. ;

Martin, Jeffrey N. ;

Klein, Marina B. ;

Jacobson, Lisa P. ;

Rodriguez, Benigno ;

Sterling, Timothy R. ;

Kirk, Gregory D. ;

Napravnik, Sonia ;

Rachlis, Anita R. ;

Calzavara, Liviana M. ;

Horberg, Michael A. ;

Silverberg, Michael J. ;

Gebo, Kelly A. ;

Goedert, James J. ;

Benson, Constance A. ;

Collier, Ann C. ;

Van Rompaey, Stephen E. ;

Crane, Heidi M. ;

McKaig, Rosemary G. ;

Lau, Bryan ;

Freeman, Aimee M. ;

Moore, Richard D. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (18) :1815-1826

[6] Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting Antivirals [J].

Naggie, Susanna ;

Sulkowski, Mark S. .

GASTROENTEROLOGY, 2012, 142 (06) :1324-+

[7] Boceprevir for Untreated Chronic HCV Genotype 1 Infection [J].

Poordad, Fred ;

McCone, Jonathan, Jr. ;

Bacon, Bruce R. ;

Bruno, Savino ;

Manns, Michael P. ;

Sulkowski, Mark S. ;

Jacobson, Ira M. ;

Reddy, K. Rajender ;

Goodman, Zachary D. ;

Boparai, Navdeep ;

DiNubile, Mark J. ;

Sniukiene, Vilma ;

Brass, Clifford A. ;

Albrecht, Janice K. ;

Bronowicki, Jean-Pierre ;

Colombato, L. ;

Curciarello, J. ;

Silva, M. ;

Tanno, H. ;

Terg, R. ;

Adler, M. ;

Langlet, P. ;

Lasser, L. ;

Nevens, F. ;

Anderson, F. ;

Bailey, R. ;

Bilodeau, M. ;

Cooper, C. ;

Feinman, S. V. ;

Heathcote, J. ;

Levstik, M. ;

Ramji, A. ;

Sherman, M. ;

Shafran, S. ;

Yoshida, E. ;

Achim, A. ;

Ben Ali, S. ;

Bigard, M-A. ;

Bonny, C. ;

Bourliere, M. ;

Boyer-Darrigrand, N. ;

Bronowicki, J-P. ;

Canva, V. ;

Couzigou, P. ;

De Ledinghen, V. ;

Guyader, D. ;

Hezode, C. ;

Larrey, D. ;

Latournerie, M. ;

Marcellin, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1195-1206

[8] Peginterferon alfa-2a Plus Ribavirin for HIV-HCV Genotype 1 Coinfected Patients: A Randomized International Trial [J].

Rodriguez-Torres, Maribel ;

Slim, Jihad ;

Bhatti, Laveeza ;

Sterling, Richard ;

Sulkowski, Mark ;

Hassanein, Tarek ;

Serrao, Rosario ;

Sola, Ricard ;

Bertasso, Anne ;

Passe, Sharon ;

Stancic, Saray .

HIV CLINICAL TRIALS, 2012, 13 (03) :142-152

[9] New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals [J].

Seden, Kay ;

Back, David ;

Khoo, Saye .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2010, 65 (06) :1079-1085

[10] Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: A cross-sectional analysis of the US adult AIDS clinical trials group [J].

Sherman, KE ;

Rouster, SD ;

Chung, RT ;

Rajicic, N .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (06) :831-837

← 1 2 →